Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00003268

Conditions: Bone Marrow Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +13 more
Locations: Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

NCT00628628

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +19 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

NCT01041040

Conditions: Acute Myeloblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hoapital La Fe Valencia, Spain

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00054327

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Progression of Hematopoietic Diseases in Shanghai, China

NCT00365014

Conditions: Anemia, Anemia, Aplastic, Bone Marrow Diseases, +11 more
Locations: Joint Sino-US Clinical and Molecular Laboratory (JCML) Shanghai, China

View Trial Details

Completed

Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML

NCT01161550

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

NCT00049686

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

3-AP and Cytarabine in Treating Patients With Hematologic Cancer

NCT00064090

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +33 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

NCT00098436

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations: American Health Network - North Illinois Street Indianapolis, Indiana, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

NCT00070538

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions